3C08
Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CHESS BEAMLINE F1 |
Synchrotron site | CHESS |
Beamline | F1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-01-07 |
Detector | ADSC QUANTUM 210 |
Wavelength(s) | 0.918 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 56.821, 61.377, 102.675 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.150 |
R-factor | 0.226 |
Rwork | 0.224 |
R-free | 0.26400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | PDB id 1L7I |
RMSD bond length | 0.012 |
RMSD bond angle | 1.329 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 52.700 | 2.230 |
High resolution limit [Å] | 2.150 | 2.150 |
Rmerge | 0.102 | 0.417 |
Number of reflections | 20191 | |
<I/σ(I)> | 7.2 | 3.618 |
Completeness [%] | 99.9 | 99.9 |
Redundancy | 5.3 | 4.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 298 | 1.8M ammonium sulfate, 0.1M MES, pH 6.5, vapor diffusion, temperature 298K |